Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Creative Commons License

Dirican A., Kucukzeybek B. B., Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., ...More

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.20, pp.70-81, 2015 (SCI-Expanded) identifier identifier identifier


Background The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with cancer. Similarly, a study in a large series has shown that the newly defined derived NLR (dNLR; neutrophil/leukocyte-lymphocyte ratio) also has prognostic value. The present study retrospectively evaluates the prognostic significance of NLR and dNLR in breast cancer.